Literature DB >> 2765447

Convulsion following intravenous fluorescein angiography.

S P Kelly1, N J MacDermott, D C Saunders, F N Leach.   

Abstract

Tonic-clonic seizures followed intravenous fluorescein injection for fundus angiography in a 47-year-old male. Despite precautions this adverse reaction recurred on re-exposure to intravenous fluorescein.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2765447      PMCID： PMC1041839          DOI： 10.1136/bjo.73.8.655

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  4 in total

1.  Drug-induced convulsions. Report from Boston Collaborative Drug Surveillance Program.

Authors: 
Journal:  Lancet       Date:  1972-09-30       Impact factor: 79.321

2.  A unique case of grand mal seizures after fluress.

Authors:  H C Cohn; V L Jocson
Journal:  Ann Ophthalmol       Date:  1981-12

3.  [Acute neurological complications following intrathecal fluorescein injection (author's transl)].

Authors:  K Mees; A Beyer
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1982-02

Review 4.  Fluorescein angiography complication survey.

Authors:  L A Yannuzzi; K T Rohrer; L J Tindel; R S Sobel; M A Costanza; W Shields; E Zang
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079
  4 in total
  2 in total

1.  Evaluation of Potential Systemic Adverse Events Related to Fluorescein Angiography in Pediatric Patients.

Authors:  Ru-Ik Chee; Mrinali P Gupta; Nita G Valikodath; Emily Cole; Anton Orlin; Tala Al-Khaled; Irene Rusu; Samir N Patel; June Han; Vivien Yap; Karyn E Jonas; Peter J Campbell; Michael F Chiang; R V Paul Chan
Journal:  Ophthalmol Retina       Date:  2019-12-16

Review 2.  The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines.

Authors:  Alireza Mardanshahi; Nasrin Abbasi Gharibkandi; Samaneh Vaseghi; Seyed Mohammad Abedi; Sajjad Molavipordanjani
Journal:  Mol Biol Rep       Date:  2021-08-06       Impact factor: 2.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.